Oncology

Please select a category to find your test or learn more about our highlighted tests below

  • Breast
  • Gastrointestinal
  • Gynecologic
  • Urologic
  • Tumor Testing
    • Testing Options
      • Name TAT Genes
        TumorNext-HRD 3-4 weeks 11
        TumorNext-Lynch 3-4 weeks 8
        Microsatellite instability (MSI) analysis 3-4 weeks 0
  • Comprehensive
    • comprehensive testing
      • Name TAT Genes
        CustomNext-Cancer 14-21 days 67
        CancerNext-Expanded 14-21 days 67
        CancerNext 14-21 days 34
  • Other
  • Single Gene
    • Single gene testing options
      • Name TAT
        AIP gene sequence and deletion/duplication 14-21 days
        ALK gene sequence and deletion/duplication 14-21 days
        APC gene sequence and deletion/duplication analysis 14-21 days
        ATM gene sequence and deletion/duplication analysis 14-21 days
        BAP1 gene sequence and deletion/duplication analysis 14-21 days
        BARD1 gene sequence and deletion/duplication analysis 14-21 days
        BRCA1/BRCA2 gene sequence and deletion/duplication analysis 6-10 days
        BRIP1 gene sequence and deletion/duplication analysis 14-21 days
        BMPR1A/SMAD4 gene sequence and deletion/duplication analysis 14-21 days
        CDH1 gene sequence and deletion/duplication analysis 14-21 days
        CDKN1B gene sequence and deletion/duplication 14-21 days
        CDKN2A/CDK4 gene sequence and deletion/duplication analysis 14-21 days
        CHEK2 gene sequence and deletion/duplication analysis 14-21 days
        DICER1 gene sequence and deletion/duplication analysis 14-21 days
        EPCAM deletion/duplication analysis 7-14 days
        FH gene sequence and deletion/duplication analysis 3-4 weeks
        FLCN gene sequence and deletion/duplication analysis 3-4 weeks
        GREM1 duplication analysis 14-21 days
        MAX gene sequence and deletion/duplication analysis 14-21 days
        MEN1 gene sequence and deletion/duplication analysis 14-21 days
        MET gene sequence and deletion/duplication analysis 14-21 days
        MITF specific site analysis 7-14 days
        MLH1 gene sequence and deletion/duplication analysis 14-21 days
        MRE11A gene sequence and deletion/duplication analysis 14-21 days
        MSH2 gene sequence and deletion/duplication analysis, MSH2 inversion analysis, and EPCAM deletion/duplication analysis 14-21 days
        MSH6 gene sequence and deletion/duplication analysis 14-21 days
        MUTYH gene sequence and deletion/duplication analysis 14-21 days
        NBN gene sequence and deletion/duplication analysis 14-21 days
        NF1 gene sequence and deletion/duplication analysis 14-21 days
        NF2 gene sequence and deletion/duplication 14-21 days
        PALB2 gene sequence and deletion/duplication analysis 14-21 days
        PMS2 gene sequence and deletion/duplication analysis 2-5 weeks
        POLD1/POLE gene sequence analysis 14-21 days
        POT1 gene sequence and deletion/duplication 14-21 days
        PHOX2B gene sequence and deletion/duplication 14-21 days
        PRKAR1A gene sequence and deletion/duplication 14-21 days
        PTCH1 gene sequence and deletion/duplication analysis 14-21 days
        PTEN gene sequence and deletion/duplication analysis 14-21 days
        RAD50 gene sequence and deletion/duplication analysis 14-21 days
        RAD51C gene sequence and deletion/duplication analysis 14-21 days
        RAD51D gene sequence and deletion/duplication analysis 14-21 days
        RB1 gene sequence and deletion/duplication analysis 14-21 days
        RET gene sequence 14-21 days
        SDHA gene sequence and deletion/duplication analysis 14-21 days
        SDHAF2 gene sequence and deletion/duplication analysis 14-21 days
        SDHB gene sequence and deletion/duplication analysis 14-21 days
        SDHC gene sequence and deletion/duplication analysis 14-21 days
        SDHD gene sequence and deletion/duplication analysis 14-21 days
        SMARCA4 gene sequence and deletion/duplication analysis 14-21 days
        SMARCB1 gene sequence and deletion/duplication 14-21 days
        SMARCE1 gene sequence and deletion/duplication 14-21 days
        STK11 gene sequence and deletion/duplication analysis 14-21 days
        SUFU gene sequence and deletion/duplication 14-21 days
        TMEM127 gene sequence and deletion/duplication analysis 14-21 days
        TP53 gene sequence and deletion/duplication analysis 14-21 days
        TSC1/TSC2 gene sequence and deletion/duplication analysis 14-21 days
        VHL gene sequence and deletion/duplication analysis 14-21 days

why choose ambry

Ambry places significant value on implementing new lab processes designed to increase quality, and advancing technology across the field with innovative approaches. Our ongoing participation in numerous research studies and collaborations is so that we can better assess clinical validity of gene-disease relationships. This is to ensure that the results healthcare providers receive are as accurate and informative as possible. That’s why we led the largest study of its kind (20,000 cases) guiding us on additional confirmatory testing when we saw specific well-defined thresholds, reducing the chance of delivering a false positive patient report or one that misses real mutations (Mu et al., November 2016). The more accurate the reports, the more insight healthcare providers will have to treat their patients.

Choose from one of our more frequently ordered tests listed below.

CancerNext®

When finding the answer is critical for guiding your patient’s healthcare, CancerNext is a comprehensive 34-gene panel that identifies inherited risks for at least 8 types of cancers, giving you more information to make better treatment and management decisions.

CustomNext-Cancer ®

For patients with a complex personal or family history of cancer, CustomNext gives you the flexibility to choose which genes to analyze so you can accurately diagnose, treat, and manage your patient’s cancer risks.

BreastNext®

Understanding high-risk breast cancer patients such as those with early-onset or multiple diagnoses of breast cancer, male breast cancer, and/or with a family history of disease is made clearer with BreastNext, a 17-gene panel, offering more precision to identify and manage hereditary breast cancer.

OvaNext®

Every patient diagnosed with epithelial ovarian cancer meets criteria for hereditary cancer genetic testing. OvaNext, a 25-gene panel, offers the most comprehensive testing for gynecologic cancers to increase the chance of identifying and managing hereditary cancer risks.

ProstateNext®

Since hereditary prostate cancer is not well understood or often recognized, clinicians need clear results to guide treatment decisions. ProstateNext is a 14-gene panel which offers more precision to identify and manage hereditary prostate cancer.

ColoNext®

Patients with a suspicious personal or family history of colorectal cancer or polyps benefit from early detection and cancer prevention. Identify patients with an increased risk by using ColoNext, a 17-gene panel designed to provide more precise data to help guide personalized medical management recommendations such as earlier or more frequent colonoscopies.

BRCAplus-Expanded ®

To understand your patient’s risk and minimize uncertain results, you need a genetic test designed specifically for patients with a high risk personal and/or family breast cancer history. BRCAplus-Expanded tests critical breast cancer genes with published guidelines for medical management, so you can help your patient make confident, personalized screening and prevention decisions.

TumorNext-HRD

TumorNext-HRD clearly determines patients who may benefit from treatment with PARP inhibitors in one simple test. It simultaneously understands hereditary risk as it detects and differentiates between germline and somatic mutations in homologous recombination repair genes including BRCA1 and BRCA2.

TumorNext-Lynch

When you need to rule out or confirm Lynch syndrome or to determine if your patient can start PD-LI or PD-1 immunotherapy, you need a test that gives you the most comprehensive and accurate information. TumorNext-Lynch is a single test that looks at both tumor and germline mutations, giving you clearer information to better guide treatment decisions.

Search Results

Start your search...